All In MedTech

FDA Clearance Tracker · P140009-S047

Brio Neurostimulation System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 15, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 15, 2019

Approved

Time to decision

69 days

Received May 7, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P140009-S047
Device name
Brio Neurostimulation System
Applicant location
Plano, TX
Received
May 7, 2019
Decided
Jul 15, 2019
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P140009

Device type

Device class
Class III

Every decision under product code MHY

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Midwest Sterilization Corporation, 1204 Lenco Avenue, Jackson, Missouri, as an alternate ethylene oxide sterilization site for numerous neuromodulation products.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.